Yoon-Koo Kang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 44

Top Topics

Locally Advanced

Metastatic Renal Cell Carcinoma

Neoadjuvant Chemotherapy

Top Venues

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Hyung-Don Kim, Min-Hee Ryu, Yoon-Koo Kang
Adjuvant treatment for locally advanced gastric cancer: an Asian perspective. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 27 (3) (2024)
Hyung-Don Kim, Min-Hee Ryu, Young Soo Park, Changhoon Yoo, Sung Joo Kim, Yoon-Koo Kang
Clinical and Biomarker Analysis of a Phase I/II Study of PDR001 plus Imatinib for Advanced Treatment-refractory Gastrointestinal Stromal Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Chung Ryul Oh, Eo Jin Kim, Heejung Chae, Young Soo Park, Min-Hee Ryu, Hyung-Don Kim, Yoon-Koo Kang
Prognostic value of mismatch repair deficiency in patients receiving first-line fluoropyrimidine plus platinum for metastatic, recurrent, or unresectable gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2024)
Hyung-Don Kim, Min-Hee Ryu, Yoon-Koo Kang
Adjuvant treatment for locally advanced gastric cancer: an Asian perspective. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 27 (3) (2024)
Hyung-Don Kim, Min-Hee Ryu, Ji Sung Lee, Yoon-Koo Kang
Letter to the editor: 5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 27 (4) (2024)
Hyung-Don Kim, Min-Hee Ryu, Young Soo Park, Changhoon Yoo, Sung Joo Kim, Yoon-Koo Kang
Clinical and Biomarker Analysis of a Phase I/II Study of PDR001 Plus Imatinib for Advanced Treatment-Refractory Gastrointestinal Stromal Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (13) (2024)
Yoon-Koo Kang, Shukui Qin, Keun-Wook Lee, Sang Cheul Oh, In-Ho Kim, Jong Gwang Kim, Yong Li, Zhuchen Yan, Jin Li, Li-Yuan Bai, Catherine Chan, Akeem Yusuf, Anita Zahlten-Kümeli, Kate Taylor, Kensei Yamaguchi
Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2024)
Chung Ryul Oh, Eo Jin Kim, Heejung Chae, Young Soo Park, Min-Hee Ryu, Hyung-Don Kim, Yoon-Koo Kang
Prognostic value of mismatch repair deficiency in patients receiving first-line fluoropyrimidine plus platinum for metastatic, recurrent, or unresectable gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 27 (4) (2024)
Yoon-Koo Kang, Hyung-Don Kim, Jeong Hwan Yook, Young-Kyu Park, Jong Seok Lee, Young-Woo Kim, Jin Young Kim, Min-Hee Ryu, Sun Young Rha, Ik Joo Chung, In-Ho Kim, Sang Cheul Oh, Young Soo Park, Jae Ho Cheong, Oh Jeong, Mi Hwa Heo, Hark Kyun Kim, ChoHyun Park, Chang Hak Yoo, Seok Yun Kang, Dae Young Zang, You-Jin Jang, Ji Young Sul, Jong Gwang Kim, Beom-Su Kim, Seung-Hoon Beom, Jun-Eul Hwang, Seung-Wan Ryu, Myeong-Cheorl Kook, Baek-Yeol Ryoo, Hyunki Kim, Moon-Won Yoo, Nam Su Lee, Sang Ho Lee, Sung Hoon Noh
Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Yoon-Koo Kang, Hyung-Don Kim, Jeong Hwan Yook, Young-Kyu Park, Jong Seok Lee, Young-Woo Kim, Jin Young Kim, Min-Hee Ryu, Sun Young Rha, Ik Joo Chung, In-Ho Kim, Sang Cheul Oh, Young Soo Park, Jae Ho Cheong, Oh Jeong, Mi Hwa Heo, Hark Kyun Kim, ChoHyun Park, Chang Hak Yoo, Seok Yun Kang, Dae Young Zang, You-Jin Jang, Ji Young Sul, Jong Gwang Kim, Beom-Su Kim, Seung-Hoon Beom, Jun-Eul Hwang, Seung-Wan Ryu, Myeong-Cheorl Kook, Baek-Yeol Ryoo, Hyunki Kim, Moon-Won Yoo, Nam Su Lee, Sang Ho Lee, Sung Hoon Noh
Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Yoon-Koo Kang, Shukui Qin, Keun-Wook Lee, Sang Cheul Oh, In-Ho Kim, Jong Gwang Kim, Yong Li, Zhuchen Yan, Jin Li, Li-Yuan Bai, Catherine Chan, Akeem Yusuf, Anita Zahlten-Kümeli, Kate Taylor, Kensei Yamaguchi
Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 27 (5) (2024)
Yoon-Koo Kang, Min-Hee Ryu, Maria Di Bartolomeo, Ian Chau, Harry Yoon, Jong Gwang Kim, Keun-Wook Lee, Sang Chul Oh, Atsuo Takashima, Anna Kryzhanivska, Yee Chao, Ludovic Evesque, Michael Schenker, Arlo McGinn, Yufan Zhao, Jennifer Lee, Lucjan Wyrwicz, Narikazu Boku
Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 27 (2) (2024)
Hyung-Don Kim, Min-Hee Ryu, Ji Sung Lee, Yoon-Koo Kang
Letter to the editor: 5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2024)
Hyung-Don Kim, Min-Hee Ryu, Ji Sung Lee, Yoon-Koo Kang
Letter to the editor: 5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2024)
Chung Ryul Oh, Eo Jin Kim, Heejung Chae, Young Soo Park, Min-Hee Ryu, Hyung-Don Kim, Yoon-Koo Kang
Prognostic value of mismatch repair deficiency in patients receiving first-line fluoropyrimidine plus platinum for metastatic, recurrent, or unresectable gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 27 (4) (2024)
Hyung-Don Kim, Min-Hee Ryu, Yoon-Koo Kang
Adjuvant treatment for locally advanced gastric cancer: an Asian perspective. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 27 (3) (2024)
Yoon-Koo Kang, Min-Hee Ryu, Maria Di Bartolomeo, Ian Chau, Harry Yoon, Jong Gwang Kim, Keun-Wook Lee, Sang Chul Oh, Atsuo Takashima, Anna Kryzhanivska, Yee Chao, Ludovic Evesque, Michael Schenker, Arlo McGinn, Yufan Zhao, Jennifer Lee, Lucjan Wyrwicz, Narikazu Boku
Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2024)
Narikazu Boku, Takeshi Omori, Kohei Shitara, Shinichi Sakuramoto, Kensei Yamaguchi, Ken Kato, Shigenori Kadowaki, Kunihiro Tsuji, Min-Hee Ryu, Do-Youn Oh, Sang Cheul Oh, Sun Young Rha, Keun-Wook Lee, Ik-Joo Chung, Sun Jin Sym, Li-Tzong Chen, Jen-Shi Chen, Li-Yuan Bai, Takashi Nakada, Shunsuke Hagihara, Reina Makino, Eiji Nishiyama, Yoon-Koo Kang
Nivolumab plus chemotherapy in patients with HER2-negative, previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: 3-year follow-up of the ATTRACTION-4 randomized, double-blind, placebo-controlled, phase 3 trial. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2024)
Yoon-Koo Kang, Min-Hee Ryu, Maria Di Bartolomeo, Ian Chau, Harry Yoon, Jong Gwang Kim, Keun-Wook Lee, Sang Chul Oh, Atsuo Takashima, Anna Kryzhanivska, Yee Chao, Ludovic Evesque, Michael Schenker, Arlo McGinn, Yufan Zhao, Jennifer Lee, Lucjan Wyrwicz, Narikazu Boku
Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2024)
Yoon-Koo Kang, Hyung-Don Kim, Jeong Hwan Yook, Young-Kyu Park, Jong Seok Lee, Young-Woo Kim, Jin Young Kim, Min-Hee Ryu, Sun Young Rha, Ik Joo Chung, In-Ho Kim, Sang Cheul Oh, Young Soo Park, Jae Ho Cheong, Oh Jeong, Mi Hwa Heo, Hark Kyun Kim, ChoHyun Park, Chang Hak Yoo, Seok Yun Kang, Dae Young Zang, You-Jin Jang, Ji Young Sul, Jong Gwang Kim, Beom-Su Kim, Seung-Hoon Beom, Jun-Eul Hwang, Seung-Wan Ryu, Myeong-Cheorl Kook, Baek-Yeol Ryoo, Hyunki Kim, Moon-Won Yoo, Nam Su Lee, Sang Ho Lee, Sung Hoon Noh
Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Yoon-Koo Kang, Min-Hee Ryu, Maria Di Bartolomeo, Ian Chau, Harry Yoon, Jong Gwang Kim, Keun-Wook Lee, Sang Chul Oh, Atsuo Takashima, Anna Kryzhanivska, Yee Chao, Ludovic Evesque, Michael Schenker, Arlo McGinn, Yufan Zhao, Jennifer Lee, Lucjan Wyrwicz, Narikazu Boku
Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 27 (2) (2024)
Hyung-Don Kim, Min-Hee Ryu, Ji Sung Lee, Yoon-Koo Kang
Letter to the editor: 5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 27 (4) (2024)
Hyung-Don Kim, Min-Hee Ryu, Ji Sung Lee, Yoon-Koo Kang
Letter to the editor: 5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 27 (4) (2024)
Hyung-Don Kim, Min-Hee Ryu, Yoon-Koo Kang
Adjuvant treatment for locally advanced gastric cancer: an Asian perspective. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2024)
Hyung-Don Kim, Min-Hee Ryu, Ji Sung Lee, Yoon-Koo Kang
Letter to the editor: 5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 27 (4) (2024)
Yoon-Koo Kang, Min-Hee Ryu, Maria Di Bartolomeo, Ian Chau, Harry Yoon, Jong Gwang Kim, Keun-Wook Lee, Sang Chul Oh, Atsuo Takashima, Anna Kryzhanivska, Yee Chao, Ludovic Evesque, Michael Schenker, Arlo McGinn, Yufan Zhao, Jennifer Lee, Lucjan Wyrwicz, Narikazu Boku
Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 27 (2) (2024)
Yoon-Koo Kang, Shukui Qin, Keun-Wook Lee, Sang Cheul Oh, In-Ho Kim, Jong Gwang Kim, Yong Li, Zhuchen Yan, Jin Li, Li-Yuan Bai, Catherine Chan, Akeem Yusuf, Anita Zahlten-Kümeli, Kate Taylor, Kensei Yamaguchi
Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 27 (5) (2024)
Hyung-Don Kim, Min-Hee Ryu, Yoon-Koo Kang
Adjuvant treatment for locally advanced gastric cancer: an Asian perspective. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 27 (3) (2024)
Yoon-Koo Kang, Min-Hee Ryu, Maria Di Bartolomeo, Ian Chau, Harry Yoon, Jong Gwang Kim, Keun-Wook Lee, Sang Chul Oh, Atsuo Takashima, Anna Kryzhanivska, Yee Chao, Ludovic Evesque, Michael Schenker, Arlo McGinn, Yufan Zhao, Jennifer Lee, Lucjan Wyrwicz, Narikazu Boku
Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 27 (2) (2024)
Yoon-Koo Kang, Shukui Qin, Keun-Wook Lee, Sang Cheul Oh, In-Ho Kim, Jong Gwang Kim, Yong Li, Zhuchen Yan, Jin Li, Li-Yuan Bai, Catherine Chan, Akeem Yusuf, Anita Zahlten-Kümeli, Kate Taylor, Kensei Yamaguchi
Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 27 (5) (2024)
Chung Ryul Oh, Eo Jin Kim, Heejung Chae, Young Soo Park, Min-Hee Ryu, Hyung-Don Kim, Yoon-Koo Kang
Prognostic value of mismatch repair deficiency in patients receiving first-line fluoropyrimidine plus platinum for metastatic, recurrent, or unresectable gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 27 (4) (2024)
Yoon-Koo Kang, Hyung-Don Kim, Hyun Jin Kim, Young Soo Park, Mo-Youl Beck, Min-Hee Ryu
Interruption of imatinib in advanced gastrointestinal stromal tumor after prolonged imatinib maintenance in the absence of gross tumor lesions. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2023)
Eo Jin Kim, Heejung Chae, Young-Soo Park, Min-Hee Ryu, Hyung-Don Kim, Junyoung Shin, Yang Soon Park, Mee Sun Moon, Yoon-Koo Kang
Clinical outcomes of Epstein-Barr virus (EBV)-associated metastatic and locally advanced unresectable gastric cancers (GCs) in patients receiving first-line fluoropyrimidine and platinum (FP) doublet chemotherapy. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2023)
Jaewon Hyung, Hyungwoo Cho, Hyung-Don Kim, Young Soo Park, Meesun Moon, Min-Hee Ryu, Yoon-Koo Kang
DNA mismatch repair deficiency and outcomes of patients with locally advanced gastric cancer treated with preoperative docetaxel, oxaliplatin, and S-1 plus surgery and postoperative S-1 or surgery plus postoperative S-1: a sub-analysis of the phase 3 PRODIGY trial. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2023)
Sebastian Bauer, Robin L Jones, Jean Yves Blay, André B P van Kuilenburg, Suzanne George, Patrick Schöffski, Margaret von Mehren, John R Zalcberg, Yoon-Koo Kang, Albiruni Abdul Razak, Jonathan C Trent, Steven Attia, Axel Le Cesne, Ying Su, Julie Meade, Tao Wang, Matthew L Sherman, Rodrigo Ruiz-Soto, Michael C Heinrich
Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (34) (2022)
Kyunghye Bang, Jaekyung Cheon, Young Soo Park, Hyung-Don Kim, Min-Hee Ryu, Yangsoon Park, Meesun Moon, Hyungeun Lee, Yoon-Koo Kang
Association between HER2 heterogeneity and clinical outcomes of HER2-positive gastric cancer patients treated with trastuzumab. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 25 (4) (2022)
Hyung-Don Kim, Jong Seok Lee, Young Soo Park, Jeong Hwan Yook, Sung Hoon Noh, Young-Kyu Park, Young-Woo Kim, Sang Cheul Oh, Jong Gwang Kim, Min-Hee Ryu, Jae-Ho Cheong, HyunKi Kim, Joon Seok Lim, Jae-Hyuk Lee, Suk Hee Heo, Jin Young Kim, Mi Hwa Heo, Young Iee Park, In-Ho Kim, Yoon-Koo Kang
Determinants of clinical outcomes of gastric cancer patients treated with neoadjuvant chemotherapy: a sub-analysis of the PRODIGY study. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 25 (6) (2022)
Yoon-Koo Kang, Suzanne George, Robin L Jones, Piotr Rutkowski, Lin Shen, Olivier Mir, Shreyaskumar Patel, Yongjian Zhou, Margaret von Mehren, Peter Hohenberger, Victor M Villalobos, Mehdi Brahmi, William D Tap, Jonathan C Trent, Maria A Pantaleo, Patrick Schöffski, Kevin He, Paggy Hew, Kate Newberry, Maria Roche, Michael C Heinrich, Sebastian Bauer
Avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor: A Randomized, Open-Label Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (28) (2021)
Hyung-Don Kim, Jong Seok Lee, Jeong Hwan Yook, Min-Hee Ryu, Young-Kyu Park, Jin Young Kim, Young-Woo Kim, Sang Cheul Oh, Jong Gwang Kim, Jae-Ho Cheong, Oh Jeong, Sung Hoon Noh, Yoon-Koo Kang
Radiological criteria for selecting candidates for neoadjuvant chemotherapy for gastric cancer: an exploratory analysis from the PRODIGY study. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2021)
Robin Kate Kelley, Bruno Sangro, William Harris, Masafumi Ikeda, Takuji Okusaka, Yoon-Koo Kang, Shu-Kui Qin, David Wai-Meng Tai, Ho Yeong Lim, Thomas Yau, Wei Peng Yong, Ann-Lii Cheng, Antonio Gasbarrini, Silvia Damian, Jordi Bruix, Mitesh J Borad, Johanna Bendell, Tae-You Kim, Nathan Standifer, Philip He, Mallory Makowsky, Alejandra Negro, Masatoshi Kudo, Ghassan K Abou-Alfa
Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (27) (2021)
Yoon-Koo Kang, Satoshi Morita, Taroh Satoh, Min-Hee Ryu, Yee Chao, Ken Kato, Hyun Cheol Chung, Jen-Shi Chen, Kei Muro, Won Ki Kang, Kun-Huei Yeh, Takaki Yoshikawa, Sang Cheul Oh, Li-Yuan Bai, Takao Tamura, Keun-Wook Lee, Yasuo Hamamoto, Jong Gwang Kim, Keisho Chin, Do-Youn Oh, Keiko Minashi, Jae Yong Cho, Masahiro Tsuda, Hiroki Sameshima, Li-Tzong Chen, Narikazu Boku
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2021)
Hyung-Don Kim, Min-Hee Ryu, Young Soo Park, Sun Young Lee, Meesun Moon, Yoon-Koo Kang
Insertion-deletion rate is a qualitative aspect of the tumor mutation burden associated with the clinical outcomes of gastric cancer patients treated with nivolumab. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2021)
Yoon-Koo Kang, Hyung-Don Kim, Min-Hee Ryu, Sung Hoon Noh
Reply to D.-C. Mo et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (34) (2021)
Yoon-Koo Kang, Jeong Hwan Yook, Young-Kyu Park, Jong Seok Lee, Young-Woo Kim, Jin Young Kim, Min-Hee Ryu, Sun Young Rha, Ik Joo Chung, In-Ho Kim, Sang Cheul Oh, Young Soo Park, Taeil Son, Mi Ran Jung, Mi Hwa Heo, Hark Kyun Kim, ChoHyun Park, Chang Hak Yoo, Jin-Hyuk Choi, Dae Young Zang, You-Jin Jang, Ji Young Sul, Jong Gwang Kim, Beom Su Kim, Seung-Hoon Beom, Sang Hee Cho, Seung-Wan Ryu, Myeong-Cheorl Kook, Baek-Yeol Ryoo, Hyun Ki Kim, Moon-Won Yoo, Nam Su Lee, Sang Ho Lee, Gyunji Kim, YeonJu Lee, Jee Hyun Lee, Sung Hoon Noh
PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (26) (2021)